Clinical Trial

Early Continuous Renal Replacement Therapy for Pediatric Septic Shock

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Septic shock is a major cause of morbidity and mortality in critically ill children. Continuous renal replacement therapy (CRRT) is increasingly used as adjunctive support in pediatric septic shock to improve hemodynamic stability, modulate inflammatory responses, and correct metabolic disturbances. However, evidence regarding optimal indications, timing, and clinical outcomes of early CRRT use in children remains limited. This prospective observational study aims to evaluate associations between early CRRT use and changes in hemodynamics, organ dysfunction, inflammatory cytokine levels, and short-term clinical outcomes in pediatric patients with septic shock admitted to pediatric intensive care units
Trial Details
NCT Number NCT07370753
Lead Sponsor National Children's Hospital, Vietnam
Conditions Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome, Septic Shock
Enrollment 50 participants
Start Date 2025-05-20
Primary Completion 2027-08-30 (estimated)
Study Completion 2028-03-18 (estimated)
Updated on ClinicalTrials.gov 2026-01-27